Requirement of Analgesics After Two Remifentanil Dosing Regimen in Cardiac Surgery.

Prospective double blind study comparing two remifentanil dosing protocols (0.1 and 0.3 mcg/kg/min) during cardiac surgery. Main outcome measures are postoperative opioid requirements (PCA oxycodone) and postoperative pain (VAS, verbal rating scale).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Kuopio University hospital

Kuopio, 70210, Finland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Coronary artery bypass grafting patients

Exclusion criteria

Psychiatric disorders, sleep apnea, cardiac insufficiency

Treatment and study plan

Remifentanil

Drug

remifentanil infusion

Primary outcomes

Postoperative opioid (oxycodone) consumption

Time frame: Postoperatively 48 hours

Sponsors and collaborators

Lead sponsor

Kuopio University Hospital

Other

Registry information

Acronym: REMISYD

Important dates

Study start: 2008
Primary completion: 2011
Study completion: 2011
First posted: Sep 23, 2008
Registry last updated: Sep 12, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed